Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global
biopharmaceutical company and leader in targeted C3 therapies,
today announced that the company will participate in the following
investor conferences in March:
- Raymond James 42nd Annual
Institutional Investors Conference: Fireside chat on
Monday, March 1, 2021 at 9:10 a.m. ET.
- Cowen 41st Annual Health Care
Conference: New Drug Launches panel on Wednesday, March 3,
2021 at 10:20 a.m. ET.
- Oppenheimer 31st Annual
Healthcare Conference: Fireside chat on Wednesday, March
17, 2021 at 8:40 a.m. ET.
The Raymond James and Oppenheimer Conference events will be
available via live webcast from the “Events and Presentations” page
of the “Investors and Media” section of the company’s website at
https://investors.apellis.com/events-and-presentations. Replays of
the webcasts will be available for 90 days following the event.
About ApellisApellis Pharmaceuticals, Inc. is a
global biopharmaceutical company that is committed to leveraging
courageous science, creativity, and compassion to deliver
life-changing therapies. Leaders in targeted C3 therapies, we aim
to develop transformative therapies for a broad range of
debilitating diseases that are driven by excessive activation of
the complement cascade, including those within hematology,
ophthalmology, nephrology, and neurology. For more information,
please visit www.apellis.com.